Kamada earnings were $24.9M for the trailing 12 months ending Sep 30, 2026, with 19.4% growth year over year. The latest KMDA earnings report on Sep 30, 2026 announced Q3 2026 earnings of $8.0M, down 13.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KMDA reported annual earnings of $20.2M, with 39.7% growth.
KMDA past earnings growth
How has KMDA's earnings growth performed historically?
On KMDA's earnings call on Nov 9, 2026, Kamada (NASDAQ: KMDA) reported Q3 2026 earnings per share (EPS) of $0.14, up 55.56% year over year. Total KMDA earnings for the quarter were $7.99 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.09.
As of the last Kamada earnings report, Kamada is currently profitable. Kamada's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $24.95 million, a 22.02% increase year over year.
What was KMDA's earnings growth in the past year?
As of Kamada's earnings date in Nov 9, 2026, Kamada's earnings has grown 19.44% year over year. This is 30.69 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 50.13%. KMDA earnings in the past year totalled $24.95 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.